1. Academic Validation
  2. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

  • Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12378-83. doi: 10.1073/pnas.2135217100.
Yasutomi Kamei 1 Hiroshi Ohizumi Yasushi Fujitani Tomoyuki Nemoto Toshiya Tanaka Nobuyuki Takahashi Teruo Kawada Masamitsu Miyoshi Osamu Ezaki Akira Kakizuka
Affiliations

Affiliation

  • 1 Department of Molecular Medical Science, Osaka Bioscience Institute, Osaka 565-0874, Japan.
Abstract

A well balanced body energy budget controlled by limitation of calorie uptake and/or increment of energy expenditure, which is typically achieved by proper physical exercise, is most effective against obesity and diabetes mellitus. Recently, Peroxisome Proliferator-activated Receptor (PPAR) gamma, a member of the nuclear receptor, and its cofactors have been shown to be involved in lipid metabolism and in the control of energy expenditure. Here we show that PPARgamma coactivator 1 (PGC-1) beta functions as ERRL1 (for ERR ligand 1), which can bind and activate orphan ERRs (estrogen receptor-related receptors) in vitro. Consistently, PGC-1beta/ERRL1 transgenic mice exhibit increased expression of the medium-chain acyl CoA dehydrogenase, a known ERR target and a pivotal Enzyme of mitochondrial beta-oxidation in skeletal muscle. As a result, the PGC-1beta/ERRL1 mice show a state similar to an athlete; namely, the mice are hyperphagic and of elevated energy expenditure and are resistant to obesity induced by a high-fat diet or by a genetic abnormality. These results demonstrate that PGC-1beta/ERRL1 can function as a protein ligand of ERR, and that its level contributes to the control of energy balance in vivo, and provide a strategy for developing novel antiobesity drugs.

Figures